{"id":"flumist-influenza-virus-vaccine-live","safety":{"commonSideEffects":[{"rate":null,"effect":"Nasal congestion"},{"rate":null,"effect":"Runny nose"},{"rate":null,"effect":"Sore throat"},{"rate":null,"effect":"Cough"},{"rate":null,"effect":"Fever"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Muscle aches"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"The vaccine contains weakened (attenuated) strains of influenza A and B viruses that are temperature-sensitive and can replicate efficiently in the cooler upper respiratory tract but not in the warmer lower respiratory tract or systemic circulation. This replication triggers both mucosal IgA antibodies and systemic immune responses, providing protection against influenza infection. The live attenuated approach mimics natural infection more closely than inactivated vaccines, potentially generating broader and more durable immunity.","oneSentence":"FluMist is a live attenuated influenza vaccine that replicates in the nasal mucosa to stimulate local and systemic immune responses against influenza viruses.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T04:00:23.752Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Influenza prophylaxis in children and adults aged 2-49 years"}]},"trialDetails":[{"nctId":"NCT05332899","phase":"PHASE1","title":"Influenza Human Challenge Model","status":"RECRUITING","sponsor":"Emory University","startDate":"2022-05-24","conditions":"Influenza","enrollment":80},{"nctId":"NCT05921448","phase":"EARLY_PHASE1","title":"Vaccine Pandemic Preparedness Through Airway Immunology Characterization","status":"ACTIVE_NOT_RECRUITING","sponsor":"Copenhagen Respiratory Research","startDate":"2025-05-19","conditions":"Influenza, Human","enrollment":60},{"nctId":"NCT05705440","phase":"PHASE3","title":"A Follow-up Study to Describe the Safety of Study Participants Who Received RSVPreF3 Maternal Vaccination (Any Dose) or Controls From Previous RSV MAT Studies During Any Pregnancy Conceived Post Vaccination/Control","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2023-02-07","conditions":"Respiratory Syncytial Virus Infections","enrollment":3855},{"nctId":"NCT06753474","phase":"PHASE1","title":"A/Texas Flu Challenge","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-02-04","conditions":"Influenza","enrollment":50},{"nctId":"NCT04901455","phase":"EARLY_PHASE1","title":"Responses to Live Attenuated Influenza Virus (LAIV) in Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-10-03","conditions":"COPD","enrollment":24},{"nctId":"NCT04164212","phase":"PHASE4","title":"Live Attenuated Influenza Vaccine as a Nasal Model for Influenza Infection","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2020-09-01","conditions":"Influenza","enrollment":33},{"nctId":"NCT07310472","phase":"NA","title":"Administration of the Nasal Influenza Vaccine to Children in Daycare or at a Healthcare Facility","status":"RECRUITING","sponsor":"Turku University Hospital","startDate":"2025-10-27","conditions":"Influenza Vaccination","enrollment":6000},{"nctId":"NCT02597647","phase":"PHASE1","title":"Bacterial Composition and Immune Responses in the Nose and Oropharynx During Influenza Infection","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2011-02","conditions":"Influenza","enrollment":17},{"nctId":"NCT07093281","phase":"PHASE4","title":"Intranasal LAIV Mucosal Immunity Examination","status":"NOT_YET_RECRUITING","sponsor":"University of Maryland, Baltimore","startDate":"2026-02","conditions":"Impact of Vaccination","enrollment":25},{"nctId":"NCT07240922","phase":"PHASE4","title":"The Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE III) Study","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-10-01","conditions":"Influenza","enrollment":600},{"nctId":"NCT07232745","phase":"PHASE4","title":"Mucosal and Systemic Immune Responses Induced by an Intranasal Influenza Live Attenuated Vaccine","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jiangsu Province Centers for Disease Control and Prevention","startDate":"2025-10-12","conditions":"Influenza","enrollment":60},{"nctId":"NCT06501963","phase":"PHASE4","title":"Revealing Protective Immunity to Influenza Using Systems Immunology","status":"COMPLETED","sponsor":"Emory University","startDate":"2024-10-14","conditions":"Influenza","enrollment":51},{"nctId":"NCT03816878","phase":"PHASE1","title":"Immunogenicity and Safety Study of Inactivated Subunit H5N1 Influenza Vaccine in Prior Recipients of Live Attenuated H2N2, H6N1 and H9N2 Influenza Vaccines and in H5N1 and Live Attenuated Vaccine Naïve Individuals","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-01-08","conditions":"Influenza","enrollment":32},{"nctId":"NCT07177417","phase":"PHASE4","title":"Characterizing the Human Airway Immune Response to FluMist Vaccination","status":"RECRUITING","sponsor":"Washington University School of Medicine","startDate":"2025-09-09","conditions":"Healthy Young Adults, Influenza Vaccines, Influenza Vaccine Response","enrollment":30},{"nctId":"NCT07133802","phase":"PHASE3","title":"Clinical Trial to Evaluate the Protective Efficacy and Safety of a Nasal Spray Live Attenuated Influenza Vaccine (LAIV) in Adults Aged 18-59 Years Post-Vaccination","status":"NOT_YET_RECRUITING","sponsor":"Changchun BCHT Biotechnology Co.","startDate":"2025-08","conditions":"Prevention of Influenza","enrollment":6680},{"nctId":"NCT04960397","phase":"PHASE1","title":"Assess the Safety and Immunogenicity of One or Two Doses of Sing2016 M2SR H3N2 Influenza Vaccine","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-09-10","conditions":"H3N2 Influenza","enrollment":140},{"nctId":"NCT07063849","phase":"PHASE1","title":"Pilot Influenza Challenge Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Daniel Hoft, MD, PhD","startDate":"2025-05-20","conditions":"Influenza","enrollment":12},{"nctId":"NCT05801978","phase":"PHASE4","title":"Durability of Vaccine Responses","status":"RECRUITING","sponsor":"Emory University","startDate":"2023-04-11","conditions":"Vaccine Response","enrollment":66},{"nctId":"NCT06841913","phase":"PHASE4","title":"Woodsmoke Exposure, Influenza Infection, and Nasal Immunity","status":"SUSPENDED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2026-10-01","conditions":"Smoke Exposure, Influenza","enrollment":112},{"nctId":"NCT06972810","phase":"NA","title":"Human Infection Study of H3N2 Influenza in Healthy Adults","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Melbourne","startDate":"2025-05-05","conditions":"Influenza","enrollment":12},{"nctId":"NCT04080245","phase":"EARLY_PHASE1","title":"Functional Consequences of T-bet Expression in Flu-specific Memory B Cells After Live Attenuated Influenza Vaccine (LAIV)","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2019-11-15","conditions":"Influenza, Human","enrollment":10},{"nctId":"NCT06987942","phase":"PHASE4","title":"Simultaneous Administration Study of Varicella Attenuated Live Vaccine and Trivalent Inactivated Influenza Vaccine (Split Virion)","status":"COMPLETED","sponsor":"Sinovac (Dalian) Vaccine Technology Co., Ltd.","startDate":"2024-09-21","conditions":"Varicella, Influenza Vaccine","enrollment":899},{"nctId":"NCT06620185","phase":"NA","title":"GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE","status":"RECRUITING","sponsor":"Imperial College London","startDate":"2025-04-16","conditions":"Influenza","enrollment":36},{"nctId":"NCT06077045","phase":"","title":"Uptake of the Childhood Live Attenuated Influenza Vaccine (LAIV) and Influenza-related Healthcare Resource Use in England During the 2012 to 2022 Flu Seasons; a Retrospective, Observational Study in the CPRD and HES Databases","status":"COMPLETED","sponsor":"AstraZeneca","startDate":"2023-01-18","conditions":"Influenza","enrollment":12775880},{"nctId":"NCT06609811","phase":"PHASE4","title":"The Interaction Between Mucosal Microbiota Colonization and the Immune Response to an Intranasal Influenza Live Attenuated Vaccine","status":"COMPLETED","sponsor":"Jiangsu Province Centers for Disease Control and Prevention","startDate":"2024-09-21","conditions":"Influenza","enrollment":200},{"nctId":"NCT00417560","phase":"NA","title":"Inactivated Influenza A/H5N1 Vaccine in Adult Subjects at Risk of Occupational Exposure to Live H5N1 Viruses","status":"WITHDRAWN","sponsor":"Centers for Disease Control and Prevention","startDate":"2007-01","conditions":"Influenza","enrollment":""},{"nctId":"NCT05691790","phase":"NA","title":"Older People's Preventive Care Utilization","status":"RECRUITING","sponsor":"The University of Hong Kong","startDate":"2024-10-01","conditions":"Health Communication","enrollment":270},{"nctId":"NCT05290792","phase":"NA","title":"Use of Wearable Sensors for Early Detection and Tracking of Viral Respiratory Tract Infections","status":"COMPLETED","sponsor":"Emily McDonald","startDate":"2021-12-10","conditions":"Viral Respiratory Tract Infection, Influenza","enrollment":56},{"nctId":"NCT03898986","phase":"PHASE1","title":"The Effects of Attenuated Versus Inactivated Flu Vaccine in Twin Sets","status":"COMPLETED","sponsor":"Stanford University","startDate":"2019-10-08","conditions":"Influenza","enrollment":18},{"nctId":"NCT03312699","phase":"PHASE1","title":"Effects of Aging on Primary and Secondary Vaccine Responses","status":"COMPLETED","sponsor":"Stanford University","startDate":"2017-09-19","conditions":"Influenza, Hepatitis A, Typhoid","enrollment":54},{"nctId":"NCT05223179","phase":"PHASE1","title":"Intramuscular CodaVax-H1N1 in Healthy Adults","status":"COMPLETED","sponsor":"Codagenix, Inc","startDate":"2022-04-11","conditions":"Influenza, Human","enrollment":69},{"nctId":"NCT03735147","phase":"PHASE4","title":"Assessment of Viral Shedding Week Following Administration of Live Attenuated Influenza Vaccine in Children","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2018-10-23","conditions":"Influenza Vaccines","enrollment":12},{"nctId":"NCT01006798","phase":"PHASE1","title":"Safety and Immunogenicity of Replication-Competent Adenovirus 4-vectored Vaccine for Avian Influenza H5N1","status":"COMPLETED","sponsor":"Emergent BioSolutions","startDate":"2009-10","conditions":"Bird Flu, Influenza","enrollment":166},{"nctId":"NCT06280144","phase":"PHASE4","title":"Post-marketing Study of Lyophilized Nasal Spray Live Attenuated Influenza Vaccine","status":"UNKNOWN","sponsor":"Changchun BCHT Biotechnology Co.","startDate":"2023-09-22","conditions":"Influenza Prevention","enrollment":6080},{"nctId":"NCT06208683","phase":"PHASE4","title":"The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior High School Students","status":"UNKNOWN","sponsor":"Sinovac Biotech Co., Ltd","startDate":"2023-11-04","conditions":"Mumps, Influenza","enrollment":400},{"nctId":"NCT01866540","phase":"NA","title":"Immune Response To Intranasal Influenza Vaccination","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Bergen","startDate":"2012-10-01","conditions":"Tonsillitis, Hypertrophy","enrollment":300},{"nctId":"NCT03884296","phase":"PHASE4","title":"Response to Live Attenuated Influenza Vaccine in Tonsillar Tissues and Blood","status":"WITHDRAWN","sponsor":"Stanford University","startDate":"2019-04-15","conditions":"Influenza","enrollment":""},{"nctId":"NCT03630705","phase":"PHASE3","title":"Safety and Immunogenicity of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the Russian Federation and Mexico","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2018-10-17","conditions":"Healthy Volunteers (Meningococcal Infection)","enrollment":525},{"nctId":"NCT04222595","phase":"NA","title":"FluPRINT Study: Characterisation of the Immune and Transcriptional Response to LAIV","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-10-16","conditions":"Immunization","enrollment":33},{"nctId":"NCT01436396","phase":"PHASE3","title":"Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers","status":"COMPLETED","sponsor":"Sanofi Pasteur, a Sanofi Company","startDate":"2011-09-07","conditions":"Dengue, Dengue Hemorrhagic Fever, Yellow Fever","enrollment":792},{"nctId":"NCT05284851","phase":"PHASE2","title":"The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine","status":"UNKNOWN","sponsor":"Changchun BCHT Biotechnology Co.","startDate":"2022-04-01","conditions":"Influenza Prevention","enrollment":2520},{"nctId":"NCT02487147","phase":"NA","title":"Evaluation of Free Air Portable Air Powered Respirator","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2016-11-14","conditions":"Influenza","enrollment":58},{"nctId":"NCT04110366","phase":"NA","title":"Nasal and Systemic Immune Responses to Nasal Influenza Vaccine","status":"COMPLETED","sponsor":"Imperial College Healthcare NHS Trust","startDate":"2018-06-14","conditions":"Influenza, Vaccine Virus Shedding","enrollment":48},{"nctId":"NCT00091702","phase":"PHASE1, PHASE2","title":"Safety of and Immune Response to Two Influenza Vaccines in HIV Infected Children and Adolescents","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Influenza","enrollment":300},{"nctId":"NCT02747407","phase":"","title":"Qualitative, Qualitative, and Functional Studies Over the First Year in Measuring Immune System Response During the First Year of Therapy in Patients With Brain Tumors","status":"COMPLETED","sponsor":"Wake Forest University Health Sciences","startDate":"2016-05","conditions":"Astrocytoma, Glioma, Oligodendroglioma","enrollment":55},{"nctId":"NCT03553940","phase":"PHASE1","title":"H3N2 M2SR in Pediatric Population","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2018-08-15","conditions":"Influenza, Influenza Immunisation","enrollment":43},{"nctId":"NCT03023683","phase":"PHASE4","title":"Protective Mechanisms Against a Pandemic Respiratory Virus (SLVP024)","status":"COMPLETED","sponsor":"Stanford University","startDate":"2012-10","conditions":"Influenza","enrollment":18},{"nctId":"NCT03020472","phase":"PHASE4","title":"Kinetics of B-Cell Responses to Live, Attenuated Influenza Vaccine (LAIV) in Young Children Two Years of Age","status":"TERMINATED","sponsor":"Stanford University","startDate":"2008-11","conditions":"Influenza","enrollment":6},{"nctId":"NCT03982069","phase":"PHASE4","title":"Immunologic Response to FluMist vs. Flucelvax","status":"COMPLETED","sponsor":"Richard Zimmerman MD","startDate":"2019-09-20","conditions":"Influenza, Human, Immune Response","enrollment":465},{"nctId":"NCT03956329","phase":"NA","title":"Flu and Mood in Older Adults","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2019-08-12","conditions":"Vaccination, Infection","enrollment":654},{"nctId":"NCT00461981","phase":"PHASE2","title":"A Phase 2 Study to Evaluate Immune Responses of FluMist®","status":"COMPLETED","sponsor":"MedImmune LLC","startDate":"2007-05","conditions":"Influenza Vaccine","enrollment":101},{"nctId":"NCT04809389","phase":"PHASE1","title":"A Study to Evaluate Safety and Immunogenicity of DelNS1-nCoV-RBD LAIV for COVID-19","status":"UNKNOWN","sponsor":"The University of Hong Kong","startDate":"2021-03-29","conditions":"Covid19","enrollment":115},{"nctId":"NCT05056519","phase":"PHASE1","title":"The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine","status":"UNKNOWN","sponsor":"Changchun BCHT Biotechnology Co.","startDate":"2021-09-20","conditions":"Influenza Prevention","enrollment":160},{"nctId":"NCT00192387","phase":"PHASE2","title":"Trial to Investigate Viral Shedding in Healthy Children Vaccinated With Vaccine Virus Liquid (CAIV-T)","status":"COMPLETED","sponsor":"MedImmune LLC","startDate":"2001-09","conditions":"Influenza","enrollment":60},{"nctId":"NCT00192192","phase":"PHASE3","title":"Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine, Trivalent, Types A & B, Live Cold Adapted (CAIV-T) in Healthy Adults","status":"COMPLETED","sponsor":"MedImmune LLC","startDate":"2000-11","conditions":"Influenza","enrollment":20},{"nctId":"NCT00192231","phase":"PHASE3","title":"Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine,(CAIV-T)","status":"COMPLETED","sponsor":"MedImmune LLC","startDate":"2001-04","conditions":"Influenza","enrollment":120},{"nctId":"NCT00128167","phase":"PHASE3","title":"Trivalent, Live, Cold Adapted Influenza Vaccine (CAIV-T) Against Inactivated Influenza Vaccine (TIV) in Children 6-59 Months of Age","status":"COMPLETED","sponsor":"MedImmune LLC","startDate":"2004-10","conditions":"Influenza","enrollment":8500},{"nctId":"NCT00192348","phase":"PHASE1","title":"A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial to Assess the Safety and Tolerability of Influenza Virus Vaccine,(CAIV-T) in Healthy Infants","status":"COMPLETED","sponsor":"MedImmune LLC","startDate":"2002-05","conditions":"Healthy","enrollment":120},{"nctId":"NCT02559505","phase":"NA","title":"Influenza Immunity in Children","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2015-10","conditions":"Influenza","enrollment":134},{"nctId":"NCT04044352","phase":"PHASE1","title":"H1N1v Virus Challenge Study in Healthy Subjects","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-10-22","conditions":"Influenza","enrollment":76},{"nctId":"NCT04825340","phase":"NA","title":"To Explore a Bridging Index for the Effectiveness of the Clinical Trial","status":"UNKNOWN","sponsor":"Changchun BCHT Biotechnology Co.","startDate":"2021-04-16","conditions":"Randomized","enrollment":450},{"nctId":"NCT03600428","phase":"PHASE4","title":"Safety of LAIV4 in Children With Asthma","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2018-10-15","conditions":"Asthma in Children, Vaccine Adverse Reaction, Vaccine Reaction","enrollment":152},{"nctId":"NCT03300050","phase":"PHASE1","title":"Safety and Immunogenicity of a Live-attenuated Universal Flu Vaccine Followed by an Inactivated Universal Flu Vaccine","status":"COMPLETED","sponsor":"PATH","startDate":"2017-10-10","conditions":"Influenza, Vaccine","enrollment":65},{"nctId":"NCT01673425","phase":"NA","title":"Evaluating Immune Response to Seasonal FluMist in Healthy Adults","status":"TERMINATED","sponsor":"National Center for Occupational Health and Infection Control","startDate":"2012-09","conditions":"Influenza","enrollment":5},{"nctId":"NCT04146623","phase":"PHASE1","title":"Safety Study of Live Attenuated Influenza Vaccine, CodaVax, Delivered Via Intranasal Spray","status":"COMPLETED","sponsor":"Codagenix, Inc","startDate":"2019-05-07","conditions":"Influenza","enrollment":33},{"nctId":"NCT02501421","phase":"PHASE1","title":"Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine","status":"COMPLETED","sponsor":"Research Institute for Biological Safety Problems","startDate":"2013-10","conditions":"Tuberculosis","enrollment":44},{"nctId":"NCT02111512","phase":"PHASE4","title":"Safety of Nasal Influenza Immunisation in Egg Allergic Children - The SNIFFLE 2 Study","status":"COMPLETED","sponsor":"University Hospital Southampton NHS Foundation Trust","startDate":"2014-09","conditions":"Egg Hypersensitivity","enrollment":779},{"nctId":"NCT01859039","phase":"","title":"Safety of Nasal Influenza Immunisation in Egg Allergic Children","status":"COMPLETED","sponsor":"University Hospital Southampton NHS Foundation Trust","startDate":"2013-09","conditions":"Egg Hypersensitivity","enrollment":282},{"nctId":"NCT03926416","phase":"PHASE1","title":"Safety Study of Live Attenuated Influenza Vaccine, CodaVax","status":"COMPLETED","sponsor":"Codagenix, Inc","startDate":"2017-02-21","conditions":"Influenza","enrollment":125},{"nctId":"NCT02972957","phase":"PHASE4","title":"A Study of Intranasal Live Attenuated Influenza Vaccine Immunogenicity and Associations With the Nasopharyngeal Microbiome Among Children in the Gambia","status":"COMPLETED","sponsor":"London School of Hygiene and Tropical Medicine","startDate":"2017-01-30","conditions":"Influenza","enrollment":364},{"nctId":"NCT03453801","phase":"PHASE1","title":"The Role of CD4+ Memory Phenotype, Memory, and Effector T Cells in Vaccination and Infection","status":"COMPLETED","sponsor":"Stanford University","startDate":"2014-09-30","conditions":"Influenza, Healthy","enrollment":80},{"nctId":"NCT03088904","phase":"PHASE1","title":"Genetic and Environmental Factors in the Response to Influenza Vaccination","status":"COMPLETED","sponsor":"Stanford University","startDate":"2014-10-03","conditions":"Influenza, Healthy","enrollment":109},{"nctId":"NCT02251288","phase":"PHASE1","title":"A Phase I Study Priming With an Inactivated A/H7N9 Influenza Virus Vaccine With or Without MF59 Adjuvant Followed by Live Attenuated A/H7N9 Influenza Virus Vaccine","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-05-18","conditions":"Avian Influenza, Immunisation","enrollment":62},{"nctId":"NCT04106817","phase":"PHASE1","title":"Single Ascending Dose Challenge Study to Determine Safety and Reactogenicity of an Influenza Challenge Virus","status":"COMPLETED","sponsor":"WCCT Global","startDate":"2015-01-19","conditions":"Influenza","enrollment":35},{"nctId":"NCT01443936","phase":"PHASE1","title":"Experimental AD4-H5-VTN Vaccine in Healthy Volunteers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-09-14","conditions":"H5N1 Influenza","enrollment":96},{"nctId":"NCT02549365","phase":"PHASE4","title":"Efficacy & Safety of Nasal Influenza Immunisation in Children","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2015-10","conditions":"Influenza Vaccines Efficacy and Safety","enrollment":276},{"nctId":"NCT02594189","phase":"PHASE1","title":"Influenza A H3N2 Human Challenge Study in Healthy Adult Volunteers","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2015-10-31","conditions":"Determine Minimally to Moderately Infective Dose (MMID) of Influenza A H3N2","enrollment":49},{"nctId":"NCT01730144","phase":"","title":"Studying Cell Immune Responses to a Live Flu Vaccine in Healthy Adults","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-11-17","conditions":"Normal Physiology","enrollment":10},{"nctId":"NCT03104790","phase":"PHASE4","title":"Assessment of Viral Shedding in Children Previously in Receipt of Multiple Doses of Live Attenuated Influenza Vaccine (LAIV) Compared to Influenza Vaccine-naïve Controls","status":"COMPLETED","sponsor":"Public Health England","startDate":"2017-10-02","conditions":"Influenza Vaccination, Influenza, Vaccination","enrollment":373},{"nctId":"NCT03144518","phase":"NA","title":"Mood and Influenza Vaccine Response: A Feasibility Trial","status":"COMPLETED","sponsor":"University of Nottingham","startDate":"2017-09-01","conditions":"Vaccination; Infection","enrollment":106},{"nctId":"NCT02642237","phase":"NA","title":"The Effects of Preceding LPS Administration on the Fluenz-induced Immune Response","status":"COMPLETED","sponsor":"Radboud University Medical Center","startDate":"2015-12","conditions":"Innate Immune Response, Immune Tolerance","enrollment":30},{"nctId":"NCT02866942","phase":"PHASE4","title":"Safety of Nasal Influenza Immunisation in Children With Asthma","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2016-10","conditions":"Asthma","enrollment":479},{"nctId":"NCT01511419","phase":"PHASE1","title":"Safety Trial of Live Attenuated Influenza (H7N3) Vaccine","status":"COMPLETED","sponsor":"PATH","startDate":"2012-04","conditions":"Influenza, Avian Influenza","enrollment":40},{"nctId":"NCT03581903","phase":"PHASE1","title":"A Study in Healthy Adults to Assess Priming With Antigenically Mismatched Live Attenuated A/H7N3 Influenza Virus Vaccine Followed by Inactivated A/H7N9 Influenza Virus Vaccine","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2017-09-19","conditions":"Influenza","enrollment":20},{"nctId":"NCT03101462","phase":"PHASE4","title":"Live Attenuated Influenza Vaccine (LAIV) Versus Trivalent Inactivated Influenza Vaccine in Healthy Adults 18-49 Years","status":"COMPLETED","sponsor":"St. Louis University","startDate":"2011-02-24","conditions":"Influenza","enrollment":38},{"nctId":"NCT01982331","phase":"PHASE1","title":"Reactogenicity, Safety and Immunogenicity of a Live Monovalent A/17/CALIFORNIA/66/395 (H2N2) Influenza Vaccine","status":"COMPLETED","sponsor":"PATH","startDate":"2013-10","conditions":"Influenza","enrollment":38},{"nctId":"NCT02153671","phase":"PHASE2","title":"Immunogenicity of H5N1 Vaccine Following H5N2","status":"COMPLETED","sponsor":"PATH","startDate":"2014-05","conditions":"Influenza Vaccine","enrollment":43},{"nctId":"NCT03028974","phase":"PHASE4","title":"Innate and Acquired Immunity to Influenza Infection and Immunization (SLVP029)","status":"COMPLETED","sponsor":"Stanford University","startDate":"2014-09-17","conditions":"Influenza","enrollment":77},{"nctId":"NCT01719783","phase":"PHASE1","title":"Reactogenicity, Safety, and Immunogenicity of a Live Monovalent H5N2 Influenza Vaccine","status":"COMPLETED","sponsor":"PATH","startDate":"2012-09","conditions":"Influenza","enrollment":40},{"nctId":"NCT03739229","phase":"PHASE1","title":"Reactogenicity, Safety and Immunogenicity of a LAIV А/17/Hong Kong/2017/75108 H7N9 Influenza Vaccine","status":"UNKNOWN","sponsor":"Research Institute of Influenza, Russia","startDate":"2018-12-03","conditions":"Vaccine Adverse Reaction","enrollment":40},{"nctId":"NCT02519855","phase":"PHASE3","title":"Study to Evaluate Immunogenicity, Safety, and Tolerability of ZOSTAVAX™ Vaccine (Zoster Vaccine Live, V211) Administered Concomitantly Versus Nonconcomitantly With Quadrivalent Influenza Virus Vaccine (Inactivated) in Participants ≥50 Years of Age (V211-062)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2015-09-11","conditions":"Herpes Zoster","enrollment":882},{"nctId":"NCT01653015","phase":"PHASE4","title":"Live Versus Inactivated Influenza Vaccine Study in Hutterite Children","status":"COMPLETED","sponsor":"McMaster University","startDate":"2012-11","conditions":"Influenza","enrollment":4611},{"nctId":"NCT02957656","phase":"PHASE1","title":"Safety and Immunogenicity of Priming With Live Attenuated A/H7N9 Influenza Virus Vaccine Followed By Inactivated A/H7N9 Influenza Virus Vaccine With AS03 Adjuvant","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-12","conditions":"Influenza A Virus, H7N9 Subtype","enrollment":53},{"nctId":"NCT02133781","phase":"PHASE4","title":"B-cell Immunity to Influenza (SLVP017)- Year 1, 2009","status":"COMPLETED","sponsor":"Stanford University","startDate":"2009-07","conditions":"Influenza","enrollment":51},{"nctId":"NCT03020498","phase":"PHASE4","title":"B-cell Immunity to Influenza (SLVP017) - Years 2 (2010) & 3 (2011)","status":"COMPLETED","sponsor":"Stanford University","startDate":"2010-09","conditions":"Influenza","enrollment":91},{"nctId":"NCT02141581","phase":"PHASE4","title":"Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)","status":"COMPLETED","sponsor":"Stanford University","startDate":"2011-08","conditions":"Influenza","enrollment":86},{"nctId":"NCT02883426","phase":"PHASE1","title":"Evaluating the Safety and Immunogenicity of a Live Attenuated Virus Vaccine to Prevent Influenza H3N2v Disease","status":"TERMINATED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2016-09","conditions":"Influenza","enrollment":1},{"nctId":"NCT02250274","phase":"PHASE4","title":"Randomized Study of Immune Response to Licensed Influenza Vaccines in Children and Adolescents","status":"COMPLETED","sponsor":"Marshfield Clinic Research Foundation","startDate":"2014-09","conditions":"Immune Response to Influenza Vaccine, Influenza A Virus Infection, Influenza B Virus Infection","enrollment":131},{"nctId":"NCT02967393","phase":"PHASE4","title":"Influenza Vaccine Feasibility Study in Children With Persistent Asthma","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2016-10-10","conditions":"Asthmatic","enrollment":40},{"nctId":"NCT03502291","phase":"PHASE4","title":"The Effect of Live Attenuated Inactivated Influenza Vaccine on Experimental Human Pneumococcal Carriage Study","status":"COMPLETED","sponsor":"Liverpool University Hospitals NHS Foundation Trust","startDate":"2015-08","conditions":"Pneumonia, Influenza, Human","enrollment":324}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"FluMist, Influenza Virus Vaccine Live","genericName":"FluMist, Influenza Virus Vaccine Live","companyName":"MedImmune LLC","companyId":"medimmune-llc","modality":"Biologic","firstApprovalDate":"","aiSummary":"FluMist is a live attenuated influenza vaccine that replicates in the nasal mucosa to stimulate local and systemic immune responses against influenza viruses. Used for Influenza prophylaxis in children and adults aged 2-49 years.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}